Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.

Alzheimer's and Parkinson's cause similar cognitive symptoms, but show opposing patterns on MRI
This new information on the pathogenesis of both conditions could be useful for the development of interventions targeted at slowing cognitive decline.
American College of Cardiology announces late-breaking clinical trials for ACC.25
The presentations will cover a variety of topics, including coronary artery disease, semaglutide, artificial intelligence, TAVR, heart failure, PCI and much more. ACC.25 takes place March 29-31 in Chicago.
New directions and trends in interventional cardiology
Interventional cardiology continues to evolve, driven by rapid advancements in technology. George Dangas, MD, discussed some of the specialty's biggest ongoing trends with Cardiovascular Business.
Valve durability after TAVR: Cardiologists track how deterioration influences outcomes
Researchers have made it a priority to learn as much about the durability of TAVR valves as possible. A new study in JACC: Cardiovascular Interventions used updated VARC-3 definitions to identify signs of hemodynamic valve deterioration in nearly 2,500 patients.
AI-powered heart assessments of NFL veterans could help cardiologists tackle CVD
Retired NFL players Joel Dreessen and Le-Lo Lang are among the first athletes participating in a new registry launched by HeartFlow and the Boone Heart Institute.

Researchers examined data from nearly 3.9 million older adults who received the Pfizer-BioNTech COVID-19 vaccine.

The study tracked 2,876 patients hospitalized for acute HF or deteriorating chronic HF.

The study, published in JACC: Vascular Interventions, examined 619 patients who underwent PCI for LM CAD.

A new study in Science Signaling could have significant ramifications for how we view obesity-related cancers.

The study tracked five generic statins: atorvastatin, rosuvastatin, simvastatin, lovastatin and pravastatin.

The authors also noted that cardiac complications such as myocarditis, MI and new-onset heart failure were rare during hospitalization for COVID-19.

The study, published in the Journal of the American College of Cardiology, examined outcomes from more than 3,000 patients.

No such trend was reported among patients with end-stage kidney disease.